(ELV) Elevance Health Expects 2026 Adjusted EPS At Least $26.75, vs. FactSet Est of $26.85
Elevance Health (ELV) has reaffirmed its 2026 adjusted EPS guidance, expecting at least $26.75 per share. This figure is slightly below the FactSet es...
ELV
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (5)
Neutral (6)
Bearish (0)
Latest ELV News
Bullish
Elevance Health, Inc. Stock 12‑Month Price Target Raised to $406.38, Implies 4% Upside
Analysts have raised the average 12-month price target for Elevance Health, Inc. stock from $402.71 to $406.38, suggesting a 4% upside from its recent...
Bullish
Elevance Health, Inc. Stock 12‑Month Price Target Raised to $405.19, Implies 4% Upside
The average 12-month price target for Elevance Health, Inc. (ELV) stock has been raised to $405.19 by 21 analysts, up from $402.71. This new target su...
Neutral
Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade) (NYSE:ELV)
Elevance Health (ELV) has demonstrated a strong recovery, rising approximately 34% since its March lows, driven by positive sector trends and improved...
/Elevance%20Health%20Inc%20billboard-by%20monticello%20via%20Shutterstock.jpg)
Neutral
Elevance Health Stock: Is ELV Underperforming the Health Care Sector?
Elevance Health (ELV) is a large-cap health benefits company with a market cap of $85.4 billion. While ELV has recently shown strong performance, gain...
Neutral
Easterly Investment Partners LLC Has $15.11 Million Stock Holdings in Elevance Health, Inc. $ELV
Easterly Investment Partners LLC increased its holdings in Elevance Health, Inc. (NYSE:ELV – Free Report) by 59.0% in the 4th quarter, according to it...
Free phones and 24/7 care: Elevance Health tackles the digital health divide
Elevance Health is working to bridge the healthcare digital divide through programs like "Get Connected for Health" and services from its subsidiary, ...
Bullish
Barclays Adjusts Elevance Health Price Target to $480 From $408, Maintains Overweight Rating
Barclays has increased its price target for Elevance Health (ELV) to $480 from $408, while reiterating an Overweight rating on the stock. This adjustm...
Bullish
UBS Adjusts Price Target on Elevance Health to $460 From $400, Maintains Buy Rating
UBS has increased its price target for Elevance Health (ELV) to $460 from $400, while reconfirming a Buy rating on the stock. This adjustment reflects...
Neutral
How providers are responding to Elevance’s out-of-network policy
This article discusses how healthcare providers are reacting to Elevance Health's out-of-network referral penalties. The author, Caroline Hudson, publ...
Neutral
Why UnitedHealthcare and other insurers are padding reserves
Major health insurance companies, including UnitedHealthcare, Elevance Health, and Alignment, are actively increasing their financial reserves. This m...
Research ELV on:
Ad Space